每經AI快訊，威(wei)高骨科（SH 688161，收盤價：37.45元）9月5日(ri)(ri)晚間發布公(gong)(gong)告(gao)稱，山東(dong)威(wei)高骨科材料股(gu)(gu)(gu)(gu)份(fen)(fen)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)司(si)于2023年(nian)8月28日(ri)(ri)召(zhao)開第三屆董事會第四(si)次會議，審議通過了(le)《關于以(yi)集中競價交易(yi)方(fang)式回購公(gong)(gong)司(si)股(gu)(gu)(gu)(gu)份(fen)(fen)預案的(de)議案》。現將公(gong)(gong)司(si)2023年(nian)8月29日(ri)(ri)前十大(da)無限(xian)(xian)(xian)(xian)售條件股(gu)(gu)(gu)(gu)東(dong)披露如(ru)下：山東(dong)省財金(jin)投(tou)(tou)資(zi)(zi)集團有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)司(si)持(chi)(chi)約(yue)2525萬(wan)股(gu)(gu)(gu)(gu)，占(zhan)比(bi)(bi)(bi)(bi)(bi)32.94%；威(wei)海(hai)永耀貿易(yi)中心（有(you)(you)(you)限(xian)(xian)(xian)(xian)合(he)(he)伙）持(chi)(chi)約(yue)747萬(wan)股(gu)(gu)(gu)(gu)，占(zhan)比(bi)(bi)(bi)(bi)(bi)9.74%；中國(guo)銀(yin)行(xing)股(gu)(gu)(gu)(gu)份(fen)(fen)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)司(si)－華(hua)寶中證(zheng)(zheng)醫(yi)療交易(yi)型(xing)(xing)開放式指(zhi)數證(zheng)(zheng)券(quan)投(tou)(tou)資(zi)(zi)基(ji)(ji)金(jin)持(chi)(chi)約(yue)116萬(wan)股(gu)(gu)(gu)(gu)，占(zhan)比(bi)(bi)(bi)(bi)(bi)1.51%；上海(hai)國(guo)鑫(xin)投(tou)(tou)資(zi)(zi)發展有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)司(si)持(chi)(chi)約(yue)110萬(wan)股(gu)(gu)(gu)(gu)，占(zhan)比(bi)(bi)(bi)(bi)(bi)1.43%；渤(bo)海(hai)銀(yin)行(xing)股(gu)(gu)(gu)(gu)份(fen)(fen)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)司(si)－中信建投(tou)(tou)醫(yi)改靈(ling)活配(pei)置混合(he)(he)型(xing)(xing)證(zheng)(zheng)券(quan)投(tou)(tou)資(zi)(zi)基(ji)(ji)金(jin)持(chi)(chi)100萬(wan)股(gu)(gu)(gu)(gu)，占(zhan)比(bi)(bi)(bi)(bi)(bi)1.3%；易(yi)方(fang)達(da)泰和增長股(gu)(gu)(gu)(gu)票型(xing)(xing)養老金(jin)產品(pin)－中國(guo)工商銀(yin)行(xing)股(gu)(gu)(gu)(gu)份(fen)(fen)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)司(si)持(chi)(chi)約(yue)96萬(wan)股(gu)(gu)(gu)(gu)，占(zhan)比(bi)(bi)(bi)(bi)(bi)1.25%；招(zhao)商銀(yin)行(xing)股(gu)(gu)(gu)(gu)份(fen)(fen)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)司(si)－睿遠均(jun)衡價值(zhi)三年(nian)持(chi)(chi)有(you)(you)(you)期混合(he)(he)型(xing)(xing)證(zheng)(zheng)券(quan)投(tou)(tou)資(zi)(zi)基(ji)(ji)金(jin)持(chi)(chi)約(yue)91萬(wan)股(gu)(gu)(gu)(gu)，占(zhan)比(bi)(bi)(bi)(bi)(bi)1.18%；招(zhao)商銀(yin)行(xing)股(gu)(gu)(gu)(gu)份(fen)(fen)有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)司(si)－睿遠穩進配(pei)置兩年(nian)持(chi)(chi)有(you)(you)(you)期混合(he)(he)型(xing)(xing)證(zheng)(zheng)券(quan)投(tou)(tou)資(zi)(zi)基(ji)(ji)金(jin)持(chi)(chi)60萬(wan)股(gu)(gu)(gu)(gu)，占(zhan)比(bi)(bi)(bi)(bi)(bi)0.78%；戴(dai)光(guang)霞(xia)持(chi)(chi)約(yue)60萬(wan)股(gu)(gu)(gu)(gu)，占(zhan)比(bi)(bi)(bi)(bi)(bi)0.78%；瀚(han)亞(ya)投(tou)(tou)資(zi)(zi)（新加坡）有(you)(you)(you)限(xian)(xian)(xian)(xian)公(gong)(gong)司(si)－瀚(han)亞(ya)投(tou)(tou)資(zi)(zi)－中國(guo)A股(gu)(gu)(gu)(gu)增長基(ji)(ji)金(jin)－RQFII持(chi)(chi)約(yue)44萬(wan)股(gu)(gu)(gu)(gu)，占(zhan)比(bi)(bi)(bi)(bi)(bi)0.57%。前十大(da)流通股(gu)(gu)(gu)(gu)東(dong)合(he)(he)計(ji)持(chi)(chi)股(gu)(gu)(gu)(gu)約(yue)3947萬(wan)股(gu)(gu)(gu)(gu)，占(zhan)比(bi)(bi)(bi)(bi)(bi)51.48%。

2022年1至12月份，威高骨科的營業收(shou)入(ru)構成為：醫療器械制造行(xing)業占比99.96%。

威(wei)高骨科(ke)的董事長是(shi)弓劍波，男，56歲(sui)，學(xue)歷(li)背(bei)景(jing)為大專；總(zong)經理是(shi)盧均強，男，49歲(sui)，學(xue)歷(li)背(bei)景(jing)為碩(shuo)士。

截至發稿，威高(gao)骨科市值(zhi)為150億(yi)元。

道達號(hao)（daoda1997）“個股(gu)趨勢(shi)”提醒：
1. 威高骨科近30日內北向資金持股量增加21.82萬股，占流通股比例增加0.29%；
2. 近30日內共有1批機構對威高骨科調研，合計調研的機構家數為141家。
更多(duo)個股趨勢(shi)信息，請搜索微信公眾號“道達號”，回復“查詢”，領取免費查詢權限！

每經(jing)頭條（nbdtoutiao）——

(記者 尹華祿)

免責聲明：本文(wen)內(nei)容與(yu)數據僅(jin)供參考，不構成投資(zi)建議，使用前請(qing)核實。據此操作，風險(xian)自擔。